← Back to headlines
Cytokinetics Launches MYQORZO in Germany for Obstructive HCM Treatment
Cytokinetics (CYTK) has introduced its drug MYQORZO in Germany, intended for the treatment of obstructive hypertrophic cardiomyopathy (HCM).
13 Jun, 19:34 — 13 Jun, 19:34
Sources
Showing 1 of 1 sources
Related Stories
U.S. Treasury Yields Surge as Fed Official Signals Support for Rate Hike
52m ago
Kalshi Permanently Bans George Santos Over Insider Trading on State of the Union Bets
53m ago
Dell Stock Gains Investor Focus Ahead of September Earnings Report
1h ago
Sony and Warner Music Sue Anthropic Over AI Training Copyright Claims
1h ago